Addition of parsaclisib (INCB050465), a PI3K delta inhibitor, in patients with suboptimal response to ruxolitinib: A phase 2 study in patients with myelofibrosis Meeting Abstract
| Authors: | Yacoub, A.; Wang, E.; Rampal, R.; Borate, U.; Kremyanskaya, M.; Ali, H.; Hobbs, G.; O'Connell, C.; Assad, A.; Erickson-Viitanen, S.; Zhou, F.; Burn, T.; Daver, N. |
| Abstract Title: | Addition of parsaclisib (INCB050465), a PI3K delta inhibitor, in patients with suboptimal response to ruxolitinib: A phase 2 study in patients with myelofibrosis |
| Meeting Title: | 61st Annual Scientific Meeting of the British Society for Haematology |
| Journal Title: | British Journal of Haematology |
| Volume: | 193 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Apr 25-28 |
| Meeting Location: | Virtual |
| ISSN: | 0007-1048 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2021-04-01 |
| Start Page: | 9 |
| Language: | English |
| ACCESSION: | WOS:000645412200009 |
| PROVIDER: | wos |
| PUBMED: | 33928641 |
| DOI: | 10.1111/bjh.17490 |
| Notes: | Meeting Abstract: BSH2021-OR-008 -- Source: Wos |
